Acuitas Investments, LLC Lantheus Holdings, Inc. Transaction History

Acuitas Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$24.23 - $28.59 $1.19 Million - $1.41 Million	-49,267 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$19.51 - $27.64 $25.6 Million - $36.3 Million	-1,312,473 Reduced 96.38%	49,267 $1.36 Million
Q2 2021 Aug 02, 2021	BUY	$19.51 - $27.64 $24.7 Million - $34.9 Million	1,264,011 Added 1293.38%	1,361,740 $37.6 Million
Q1 2021 May 11, 2021	SELL	$13.77 - $21.66 $192,559 - $302,893	-13,984 Reduced 12.52%	97,729 $2.09 Million
Q4 2020 Feb 04, 2021	BUY	$10.75 - $14.91 $171,097 - $237,307	15,916 Added 16.61%	111,713 $1.51 Million

Q3 2020 Nov 09, 2020	BUY	$11.98 - $16.34 $1.15 Million - $1.57 Million	95,797 New	95,797 $1.21 Million

478

73M

522K

312K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.64B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.